相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cost-effectiveness of dapagliflozin in chronic heart failure: an analysis from the Australian healthcare perspective
Feby Savira et al.
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2021)
Predicting the EQ-5D utilities from the Kansas City Cardiomyopathy Questionnaire in patients with heart failure
Merrill Thomas et al.
EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES (2021)
Effects of Dapagliflozin on Symptoms, Function, and Quality of Life in Patients With Heart Failure and Reduced Ejection Fraction Results From the DAPA-HF Trial
Mikhail N. Kosiborod et al.
CIRCULATION (2020)
Effect of Dapagliflozin on Worsening Heart Failure and Cardiovascular Death in Patients With Heart Failure With and Without Diabetes
Mark C. Petrie et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure
Milton Packer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Heart Disease and Stroke Statistics-2019 Update A Report From the American Heart Association
Emelia J. Benjamin et al.
CIRCULATION (2019)
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
V. Perkovic et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
J. J. V. McMurray et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Patient-Reported Outcomes The Future of Heart Failure Care
Paul A. Heidenreich
JACC-HEART FAILURE (2019)
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
S. D. Wiviott et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Health-Related Quality of Life in Comorbid Heart Failure With Reduced Ejection Fraction and Diabetes Mellitus
Muthiah Vaduganathan et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
A Transparent and Consistent Approach to Assess US Outpatient Drug Costs for Use in Cost-Effectiveness Analyses
Joseph Levy et al.
VALUE IN HEALTH (2018)
Eighth annual INTERMACS report: Special focus on framing the impact of adverse events
James K. Kirklin et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2017)
Epidemiology of heart failure with preserved ejection fraction
Shannon M. Dunlay et al.
NATURE REVIEWS CARDIOLOGY (2017)
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
Bruce Neal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Cost-Effectiveness of Sacubitril-Valsartan in Patients Who Have Heart Failure With Reduced Ejection Fraction RESPONSE
Alexander T. Sandhu et al.
ANNALS OF INTERNAL MEDICINE (2017)
Heart Disease and Stroke Statistics-2017 Update A Report From the American Heart Association
Emelia J. Benjamin et al.
CIRCULATION (2017)
Utility of Patient-Reported Outcome Instruments in Heart Failure
Anita A. Kelkar et al.
JACC-HEART FAILURE (2016)
Factors associated with variations in hospital expenditures for acute heart failure in the United States
Boback Ziaeian et al.
AMERICAN HEART JOURNAL (2015)
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Bernard Zinman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Determinants of Utility Based on the EuroQol Five-Dimensional Questionnaire in Patients with Chronic Heart Failure and Their Change Over Time: Results from the Swedish Heart Failure Registry
Jenny Berg et al.
VALUE IN HEALTH (2015)
Quantifying the utility of taking pills for preventing adverse health outcomes: a cross-sectional survey
Robert Hutchins et al.
BMJ OPEN (2015)
Short and long term outcomes of 200 patients supported by continuous-flow left ventricular assist devices
Athanasios Tsiouris et al.
WORLD JOURNAL OF CARDIOLOGY (2015)
Patient-Accessible Tool for Shared Decision Making in Cardiovascular Primary Prevention Balancing Longevity Benefits Against Medication Disutility
Marianna Fontana et al.
CIRCULATION (2014)
ACC/AHA Statement on Cost/Value Methodology in Clinical Practice Guidelines and Performance Measures A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and Task Force on Practice Guidelines
Jeffrey L. Anderson et al.
CIRCULATION (2014)
Angiotensin-Neprilysin Inhibition versus Enalapril in Heart Failure
John J. V. McMurray et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Forecasting the Impact of Heart Failure in the United States A Policy Statement From the American Heart Association
Paul A. Heidenreich et al.
CIRCULATION-HEART FAILURE (2013)
Clinical effectiveness and cost-effectiveness of second- and third-generation left ventricular assist devices as either bridge to transplant or alternative to transplant for adults eligible for heart transplantation: systematic review and cost-effectiveness model
P. Sutcliffe et al.
HEALTH TECHNOLOGY ASSESSMENT (2013)
Fifth INTERMACS annual report: Risk factor analysis from more than 6,000 mechanical circulatory support patients
James K. Kirklin et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2013)
In-Hospital Resource Use and Medical Costs in the Last Year of Life by Mode of Death (from the HF-ACTION Randomized Controlled Trial)
Shelby D. Reed et al.
AMERICAN JOURNAL OF CARDIOLOGY (2012)
Lifetime Costs of Medical Care After Heart Failure Diagnosis
Shannon M. Dunlay et al.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2011)
Patient Health Status and Costs in Heart Failure Insights From the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS)
Paul S. Chan et al.
CIRCULATION (2009)
Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure
Michael R. MacDonald et al.
EUROPEAN HEART JOURNAL (2008)
A comparison of patient and physician-rated New York Heart Association class in a community-based heart failure clinic
Kevin M. Goode et al.
JOURNAL OF CARDIAC FAILURE (2008)
Identifying heart failure patients at high risk for near-term cardiovascular events with serial health status assessments
Mikhail Kosiborod et al.
CIRCULATION (2007)
Limitations of the New York Heart Association functional classification system and self-reported walking distances in chronic heart failure
Claire Raphael et al.
HEART (2007)
A propensity matched study of New York Heart Association class and natural history end points in heart failure
Ali Ahmed
AMERICAN JOURNAL OF CARDIOLOGY (2007)
Long-term costs and resource use in elderly participants with congestive heart failure in the Cardiovascular Health Study
Lawrence Liao et al.
AMERICAN HEART JOURNAL (2007)
Cost-effectiveness of ventricular assist device use in the United Kingdom: Results from the evaluation of ventricular assist device programme in the UK (EVAD-UK)
Linda D. Sharples et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2006)
Effect of age on short and long.-term mortality in patients admitted to hospital with congestive heart failure
F Gustafsson et al.
EUROPEAN HEART JOURNAL (2004)
Trends in heart failure incidence and survival in a community-based population
VL Roger et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
分享论文
